neffy is the first needle-free epinephrine product sold in the United States, and its price behaves differently from every auto-injector on the shelf next to it. The FDA approved the 2 mg nasal spray on August 9, 2024 for people who weigh 30 kg (66 pounds) or more, then approved a 1 mg pediatric dose on March 5, 2025 for children age four and up who weigh 15 to under 30 kg.
There is no generic version, so what you pay is decided almost entirely by which purchasing route you use. The same carton of two devices can cost $199 or over $1,000 depending on whether you ask for the manufacturer’s cash price or simply hand a prescription to a pharmacy counter. This guide covers what neffy actually costs as of September 2026 and how to land on the lower number.
What Does neffy Cost Without Insurance?
Every price below is per carton of two single-use devices, because the labeling tells patients to carry two at all times. Figures reflect data pulled on September 5, 2026.
| How you buy neffy (2 devices) | Low | Typical | High |
|---|---|---|---|
| ARS cash price (uninsured or plan does not cover neffy) | $199 | $199 | $199 |
| Discount-card price at retail (SingleCare) | $738 | $738 | $738 |
| Average retail price, no discount or program | n/a | $1,025 | n/a |
| Pharmacy acquisition cost (2026 NADAC, 2 devices) | $719 | $720 | $721 |
| Commercial insurance with the co-pay program | $0 | $0 | $200 benefit cap |
| ARS Patient Assistance Program (if eligible) | $0 | $0 | $0 |
Two of those rows are the ones worth memorizing. ARS Pharmaceuticals published the $199 cash price for two single-use devices when neffy launched, and the company’s own patient page still frames it as a ceiling, telling patients they “should not pay more than $199” if they have a high-deductible plan or a plan that does not cover neffy.
The retail figure is the trap. SingleCare listed neffy’s average retail price at $1,024.81 per box of two with prices updated September 5, 2026, and its discount-card price on the same page at $738.04. Both of those are far above the manufacturer cash price, which means walking into a pharmacy without asking for the cash program can cost you $500 to $825 extra on a single fill.
CMS NADAC data, which measures what pharmacies actually pay to acquire the drug, supports the middle of that range rather than the top. Effective August 19, 2026, NADAC listed neffy at $359.55 per 2 mg device and $360.40 per 1 mg device, or roughly $719 to $721 per carton of two before any pharmacy markup. That gap between acquisition cost and the $1,025 average retail price is the pharmacy margin you are trying to avoid.
What Drives the Price
Which route you buy through
This is the single biggest factor. The manufacturer cash price, a discount card, and a plain retail fill are three different prices for the identical product. Nothing about the medicine changes between them.
Whether you have commercial insurance
The co-pay program is restricted to commercially insured patients. If you have Medicare, Medicaid, TRICARE, VA, or DOD coverage, you are excluded from it by the program’s own terms, and so are cash-paying customers. Government-insured patients often end up paying more out of pocket than uninsured patients using the cash price, which is a recurring quirk of manufacturer programs.
Dose strength and how many cartons you need
neffy comes in a 2 mg adult and adolescent dose and a 1 mg pediatric dose. NADAC prices the two strengths within a dollar of each other, so strength is not much of a price lever. Carton count is. Families commonly keep one carton at home, one at school or daycare, and one in a bag, which triples the annual spend.
Expiration cycle
ARS reports a 24-month shelf life. That means a replacement purchase roughly every two years per carton, and expired cartons that get discovered in an emergency are the most expensive kind, since they push people toward a rushed full-price fill or an ER visit.
Pharmacy and region
Retail markups vary by chain and by state. Because neffy has no generic competitor, there is no substitution pressure holding the retail price down, which is why the spread between acquisition cost and shelf price is so wide.
Cash Price vs. Insurance
With neffy, paying cash is frequently the better deal, and that is unusual.
If you are uninsured, the $199 manufacturer cash price is almost certainly your best available number short of the assistance program. It is a published price, not a negotiated one, so you do not have to haggle for it.
If you have commercial insurance that covers neffy, the co-pay program can take your cost to $0, with ARS paying up to $200 of your cost-sharing per qualified prescription. That is better than $199, so use the insurance route. Note the cap: if your plan leaves you owing more than $200 for a fill, you pay the difference.
If you have commercial insurance with a high deductible, or a plan that does not cover neffy, the manufacturer positions $199 as the number you should not exceed. Compare that against what your plan would apply to your deductible. Paying cash keeps money off your deductible, which matters if you expect to hit it later in the year, so run both scenarios before deciding.
If you have Medicare, Medicaid, or another government plan, you cannot use the co-pay card at all. Your out-of-pocket is whatever your plan’s formulary tier sets, and it is worth asking your prescriber whether a generic auto-injector sits on a cheaper tier.
Two more notes on cards. Discount cards are not commercial payers, so they cannot be stacked with the manufacturer offer. And card prices move: the SingleCare figures above were pulled on one day and per-pharmacy prices on these sites shift between sessions, so treat them as a spread rather than a quote. Our GoodRx vs. SingleCare comparison walks through how to check both before you commit, and the GoodRx cost guide explains how those coupon prices are set.
How to Pay Less
Ask for the manufacturer cash price by name. Do not assume the pharmacy will apply it. Ask specifically for the ARS cash price of $199 for two devices, either through the manufacturer’s online pharmacy partner or with the coupon at a retail counter. This is the difference between $199 and roughly $1,025.
Apply to the Patient Assistance Program if you are uninsured. ARS provides neffy at no cost through its Patient Assistance Program for patients who are uninsured, or who are insured but have no drug coverage for neffy, and who meet the eligibility rules. Restrictions apply, so call the manufacturer’s support line before assuming you qualify.
Price the auto-injector alternatives before you commit. Generic epinephrine auto-injectors carried a NADAC acquisition cost of about $113 to $142 per device effective August 19, 2026, which is roughly a third of neffy’s. If needle-free delivery is not essential for your household, compare against our EpiPen cost guide and the Auvi-Q cost guide before filling.
Use the free virtual visit if you have commercial insurance. ARS offers a no-cost virtual visit with a prescriber for eligible commercially insured patients to get a new prescription or a refill. If you have government insurance, a fee is charged for that visit, so it is not free for everyone.
Get the prescription written at a low-cost clinic if you have no coverage. A community health center or sliding-scale clinic can write or renew the prescription for a fraction of a standard office visit, which matters when the visit costs as much as the drug. See free and sliding-scale clinics for how to find one.
Do not let a carton expire. Enroll in the manufacturer’s expiration reminder service and set your own calendar alert at 21 months. An expired device discovered during a reaction can turn a $199 problem into an emergency room bill, and our ER visit cost guide shows how large that gap gets.
If a reaction does put you in the hospital, deal with the bill. Nonprofit hospitals are required to offer financial assistance, and many uninsured patients qualify for large write-offs. Start with hospital charity care before you agree to a payment plan.
The Bottom Line
As of September 2026, the number that matters for neffy is $199 per carton of two devices, published by the manufacturer for uninsured patients and for people whose plans do not cover it. Average retail with no program attached runs roughly $1,025, and even a discount card lands near $738, so the savings come from asking for the right price rather than shopping between pharmacies.
If you have commercial coverage, the co-pay program can get you to $0 with a $200-per-fill cap. If you are uninsured and cannot manage $199, the manufacturer’s assistance program can zero it out entirely. And if the needle-free format is a preference rather than a requirement, generic auto-injectors remain the cheapest epinephrine in the country by a wide margin. Compare the routes once, then set a calendar reminder so you never have to buy in a hurry.